The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Pontus Hultén and Niki de Saint Phalle during the preparations for the exhibition Hon – en katedral ("She – A Cathedral") at the Moderna Museet in Stockholm, in 1966.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

(The Hill) – Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly ...